Article history: Anti-NogoA is a promising anti-inhibitory molecule that has been shown to enhance functional recov- Received 29 July 2011 ery after spinal cord injury when delivered in rat and primate models over the span of weeks. To Received in revised form 6 January 2012 achieve this sustained release, anti-NogoA is typically delivered by osmotic minipumps; however, exter- Accepted 15 January 2012 nal minipumps are susceptible to infection. To address this issue, we developed a drug delivery system Available online 24 January 2012 that consists of anti-NogoA-loaded poly(lactic-co-glycolic acid) nanoparticles dispersed in a hydro- gel of hyaluronan and methylcellulose (composite HAMC). To optimize in vitro release, we screened Keywords: formulations for improved anti-NogoA bioactivity and sustained release based on combinations of co- Anti-NogoA (11c7) encapsulated trehalose, hyaluronan, MgCO , and CaCO . Co-encapsulated MgCO and CaCO slowed the 3 3 3 3 Poly(lactic-co-glycolic acid) (PLGA) rate of anti-NogoA release and did not inﬂuence anti-NogoA bioactivity. Co-encapsulated trehalose sig- Nanoparticle niﬁcantly improved anti-NogoA bioactivity at early release time points by stabilizing the protein during Hydrogel Drug delivery lyophilization. Co-encapsulated trehalose with hyaluronan improved bioactivity up to 28 d and dramati- cally increased the rate and duration of sustained delivery. The
International Journal of Pharmaceutics – Elsevier
Published: Apr 15, 2012
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera